MURAGAKI Yoshihiro
Department School of Medicine(Tokyo Women's Medical University Hospital), School of Medicine Position Visiting Professor |
|
Language | English |
Title | Safety and efficacy of depatuxizumab mafodotin (ABT-414) + temozolomide (TMZ)in a Phase 2 study of Japanese patients with EGFR-amplified, recurrent glioblastoma |
Conference | the 14th Asian Society for Neuro-Oncology (ASNO 2017) |
Conference Type | Nationwide Conferences |
Presentation Type | Speech |
Lecture Type | General |
Publisher and common publisher | ◎MURAGAKI Yoshihiro, DATE Isao, KANAMORI Masayuki, KUMABE Toshihiro, MISHIMA Kazuhiko, KOBAYASHI Hiroyuki, OCAMPO Christpher, ODAGAEA Reiko, NARITA, Yoshitaka |
Date | 2017/10/31 |
Venue (city and name of the country) |
Osaka |
Society abstract | ASNO 2017 Program & Abstracts 84 |
Summary | 11:00-12:10 General scientific session 8
Clinical study Moderators: Yasuo Iwadate, Japan Se-Hyuk Kim, Korea GS8-01 |